PANCREAZE
NDC 62541-404, PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, and PANCRELIPASE PROTEASE, capsule, delayed release, from VIVUS LLC.
- Product NDC
- 62541-404
- Status
- Listed
- Labeler
- VIVUS LLC
- Dosage form
- CAPSULE, DELAYED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA022523
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62541-404 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PANCRELIPASE LIPASE16800 [USP'U]/1
- PANCRELIPASE AMYLASE98400 [USP'U]/1
- PANCRELIPASE PROTEASE56800 [USP'U]/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62541-404-10 | 62541040410 | 1 BOTTLE, GLASS in 1 CARTON (62541-404-10) / 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE, GLASS |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e8f5d2fe-728d-42af-99a6-83dddc6539c5
Use it
Look up 62541-404 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62541-404 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62541-404. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.